CINV

We supply medicinal cannabis cultivars and extracts such as GMP-Flower, GMP-Oil to the pharmaceutical industry as an API to meet the growing, global demand.

[CINV @cinvofficial]

Our work with CBG reflects controlled environments, trained teams and full plant traceability, helping protect the integrity of every CBPM produced. This shared commitment ensures consistent quality from cultivation to patient care 🌱

[CINV @cinvofficial]

🇫🇷 France has extended medical flower access again.
 But the full framework is still unpublished.
✅ EU approved
 ✅ Legal validated
 🛑 Waiting on ministers
Thousands protected — but new patients still locked out.
 #MedicalFlower #France2026 #GlobalGreenReport #PatientAccess

[CINV @cinvofficial]

UK police have new national guidance to treat prescribed CBPM users as patients first, suspects second.
 Clearer rules reduce stigma, improve patient experiences, and support the continued integration of regulated cannabinoid medicines into public systems.

[CINV @cinvofficial]

Genetics shape consistency, terpene expression, and therapeutic potential.
 Precision begins with the plant.

[CINV @cinvofficial]

Criggs Pharma delivers controlled, SAHPRA-licensed cultivation with predictable yields and strong clinical alignment.
 A core partner in CINV’s active distribution phase.

[CINV @cinvofficial]

The industry is shifting from variable supply to pharmaceutical-grade cannabinoid medicine.
CINV’s roadmap prioritises genetics, control, and consistency - building the foundations for true clinical reliability.
 2026 will be a defining year.

[CINV @cinvofficial]

Our work with CBG reflects controlled environments, trained teams and full plant traceability, helping protect the integrity of every CBPM produced. This shared commitment ensures consistent quality from cultivation to patient care 🌱

[CINV @cinvofficial]

We are pleased to announce that Rory Bowen has been appointed to our Board of Directors. We look forward to the expertise and perspective Rory will bring as we continue to advance a trusted, international seed-to-heal model for medical flower and CBPMs.
https://t.co/0MUHWsDoCi

[CINV @cinvofficial]

Patients with chronic pain average 15.3 GP visits a year (BJGP Open 2024). With that comes complex medication use.
What if one plant could replace many?
CINV is redefining patient care through high-quality, genetics-led CBPMs.

#MedicalCannabis #ChronicPain #CINV

[CINV @cinvofficial]

Heading into harvest over at Cannabudgrow 🌱

[CINV @cinvofficial]

74.1% of suicides in England and Wales in 2022 were males.

It's time to get better.

[CINV @cinvofficial]

Accredited to international standards, each cycle is managed to ensure consistency and quality for patients who rely on it.

#CBPMs #medicalflower

[CINV @cinvofficial]

BTS of modern, consistent cultivation 🌱
Cannabudgrow in Johannesburg cultivates medical flower indoors under carefully controlled conditions.

[CINV @cinvofficial]

Something for the people, for the patients, for the passion behind the plant.

We're bringing you something special.

Coming soon...

#4TP #4thepeople #4thepatient #4theplant

[CINV @cinvofficial]

But what if there was another way to support those living with chronic pain?
Patients deserve more than short-term fixes - they deserve options grounded in science, safety, and long-term wellbeing.

[CINV @cinvofficial]

📊 In 2021/22, 39.6 million opioid prescriptions were issued in England — costing the NHS £307 million. (Source: NHSBSA)
Opioids remain the most prescribed dependency-forming medication.

[CINV @cinvofficial]

Imagine if one plant did the work of all your prescriptions. 💊🌱
For many — it already does.

[CINV @cinvofficial]

What’s in your flower? 🌿
 A Certificate of Analysis (CoA) proves:
✔️ Potency
 ✔️ Terpenes
 ✔️ No mould, metals, or pesticides

[CINV @cinvofficial]

It's time to get better.
#BackPainAwareness #ChronicPain #UKHealth #MedicalFlower

[CINV @cinvofficial]

💷 The welfare bill for back pain tripled to £1.4 billion in 2022–23
 🧑‍💼 Nearly 1 million people were out of work due to back and neck issues in early 2023 - a 28% rise since 2019
We talk a lot about resilience, but it’s time we talk about relief too.

[CINV @cinvofficial]

Living in pain shouldn’t be the norm.